High dose immunoglobulin therapy in a case of inclusion body myositis: clinical and immunologic aspects
Salvarani, C.; Boiardi, L.; Maldini, M.C.; Mancini, R.; Rinaldi, M.; Macchioni, P.; Portioli, I.
Journal of Rheumatology 20(8): 1455-1456
1993
ISSN/ISBN: 0315-162X PMID: 8230050 Document Number: 413139
Document emailed within 1 workday
Related Documents
Soueidan, S.A.; Dalakas, M.C. 1993: Treatment of inclusion-body myositis with high-dose intravenous immunoglobulin Neurology 43(5): 876-879Deshmukh, S.; White, G.; Katifi, H.A.; Malik, N. 2008: Inclusion body myositis a clinical review with illustrative case report Acute Medicine 7(2): 73-76
Dobloug, C.; Walle-Hansen, R.; Gran, J.Tore.; Molberg, Øyvind. 2012: Long-term follow-up of sporadic inclusion body myositis treated with intravenous immunoglobulin: a retrospective study of 16 patients Clinical and Experimental Rheumatology 30(6): 838-842
Badrising, U.A.; Maat-Schieman, M.L.; van Duinen, S.G.; van Dijk, J.G.; Verschuuren, J.J.; Wintzen, A.R. 1998: 'Inclusion body'-myositis Nederlands Tijdschrift Voor Geneeskunde 142(11): 553-557
Mendell, J.R.; Sahenk, Z. 1992: Inclusion body myositis Neurology 42(11): 2231-2232
Gayathri, N.; Anisya-Vasanth; Veerendra Kumar, M.; Das, S.; Santosh, V.; Yasha, T.C.; Ramamohan, Y.; Taly, A.B.; Gourie-Devi, M.; Shankar, S.K. 2000: Inclusion body myositis (IBM) Clinical Neuropathology 19(1): 13-20
Alexandrescu, D.T.; Bhagwati, N.S.; Fomberstein, B.; Wolfe, D.E.; Feliz, A.; Wiernik, P.H. 2005: Steroid-responsive inclusion body myositis associated with endometrial cancer Clinical and Experimental Rheumatology 23(1): 93-96
McCoy, A.L.; Bubb, M.R.; Plotz, P.H.; Davis, J.C. 1999: Inclusion body myositis long after dermatomyositis: a report of two cases Clinical and Experimental Rheumatology 17(2): 235-239
Bertorini, T.E. 1998: Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis Comprehensive Therapy 24(10): 494-502
Albrecht, S.; Bilbao, J.M. 1993: Ubiquitin expression in inclusion body myositis. An immunohistochemical study Archives of Pathology and Laboratory Medicine 117(8): 789-793
Albayda, J.; Christopher-Stine, L.; Bingham Iii, C.O.; Paik, J.J.; Tiniakou, E.; Billings, S.; Uy, O.M.; Burlina, P. 2018: Pattern of muscle involvement in inclusion body myositis: a sonographic study Clinical and Experimental Rheumatology 36(6): 996-1002
Hoogendijk, J.E.; Bijlsma, J.W.J.; van Engelen, B.G.M.; Lindeman, E.; van Royen-Kerkhof, A.; de Rie, M.A.; de Visser, M.; Jennekens, F.G.I. 2005: The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis' Nederlands Tijdschrift Voor Geneeskunde 149(38): 2104-2111
Lindberg, C.; Oldfors, A. 1995: Inclusion body myositis. An underdiagnosed disease with creeping muscular fatigue Lakartidningen 92(10): 973-976
Dion, E.; Cherin, P.; Payan, C.; Fournet, J-Charles.; Papo, T.; Maisonobe, T.; Auberton, E.; Chosidow, O.; Godeau, P.; Piette, J-Charles.; Herson, S.; Grenier, P. 2002: Magnetic resonance imaging criteria for distinguishing between inclusion body myositis and polymyositis Journal of Rheumatology 29(9): 1897-1906
Wilson, F.C.; Ytterberg, S.R.; St Sauver, J.L.; Reed, A.M. 2008: Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota Journal of Rheumatology 35(3): 445-447
Krajnc, I. 1999: Dermatomyositis. Diagnosis and evaluation of dermatomyositis, polymyositis, and inclusion-body myositis Advances in Experimental Medicine and Biology 455: 181-186
Schmitt, K.; Tulzer, G.; Peherstorfer, K.; Sommer, R.; Tulzer, W. 1992: Long-term therapy of immune neutropenia with high-dose 7S immunoglobulin in a child Wiener Medizinische Wochenschrift 142(10): 209-212
Quartuccio, L.; De Marchi, G.; Scott, C.A.; Ferraccioli, G.; Beltrami, C.A.; De Vita, S. 2007: Treatment of inclusion body myositis with cyclosporin-A or tacrolimus: successful long-term management in patients with earlier active disease and concomitant autoimmune features Clinical and Experimental Rheumatology 25(2): 246-251
Matsuura, R.; Hamano, S.-i.; Hirata, Y.; Oba, A.; Kumagai, Y.; Suzuki, K.; Koichihara, R.; Kikuchi, K.; Tanaka, M.; Minamitani, M. 2016: Alteration of cytokines in serum and cerebrospinal fluid before and after high-dose immunoglobulin therapy in patients with West syndrome No to Hattatsu 48(4): 247-251
Jordan, S.C.; Vo, A.A.; Nast, C.C.; Tyan, D. 2003: Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience Clinical Transplants 2003: 193-198